Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

International Biotechnology Trust (IBT) Ordinary 25p Shares

Sell:612.00p Buy:618.00p 0 Change: 12.00p (1.90%)
Market closed Prices as at close on 22 March 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:612.00p
Buy:618.00p
Change: 12.00p (1.90%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed Prices as at close on 22 March 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:612.00p
Buy:618.00p
Change: 12.00p (1.90%)
Market closed Prices as at close on 22 March 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
628.00p
Trade high:
629.60p
Year high:
700.00p
Estimated NAV:
635.08
Previous close:
632.00p
Trade low:
616.20p
Year low:
518.00p
Premium/Discount:
-0.48%
Previous:
6.00p (0.94%)
Previous:
6.00p
Volume:
48,306
Dividend yield:
4.44%
Currency:
GBX
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
INT.BIOTECH. performance chart

Premium/Discount

INT.BIOTECH. performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 1.27% 1 year 1Y 11.51%
1 month 1M 2.21% 2 years 2Y 4.47%
3 months 3M 9.15% 3 years 3Y 50.3%
6 months 6M 7.74% 5 years 5Y 93.75%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: NASDAQ Biotechnology TR
Annual management charge: 0.9% of Net Assets
Performance fee: Yes
Ongoing charge: 1.18%
Dividend yield: 4.44%
Dividend frequency: None
Total assets: £241m
Gross gearing: 100%
Market capitalisation:Market cap.: £239m
Shares in issue: 37.85 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB0004559349

Recent dividends paid or declared by International Biotechnology Trust:

Type Ex-div date Payment date Amount
Interim 20/12/2018 31/01/2019 14.00p
Final 02/08/2018 31/08/2018 13.50p
Interim 04/01/2018 31/01/2018 13.50p
Final 03/08/2017 31/08/2017 11.50p
Interim 05/01/2017 31/01/2017 11.50p

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual International Biotechnology Trust dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/08/2018 2.00% -0.51 27.00p
31/08/2017 4.00% -0.20 23.00p
31/08/2016 2.30% -0.58 n/a
31/08/2015 n/a n/a n/a
31/08/2014 n/a n/a n/a

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Open an easy to manage, low cost dealing account in less than 5 minutes

Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.

More about the Fund and Share Account

Important Documents



Objective

The objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The company invests in companies that are considered to be good value with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

NET ASSET VALUE (NAV)

Estimated NAV: 635.08
Latest actual NAV: 645.49
Latest actual NAV date: 21 March 2019
Premium/Discount: -0.48%
12m average Premium/Discount: -2.01%
NAV frequency: Daily
Time / date Time Buy / sell Type Volume Price Value
16:35 - 22/03 16:35
22/03
Buy 2515 620.00p £15,593.00
16:24 - 22/03 16:24
22/03
Buy 1097 616.44p £6,762.35
16:21 - 22/03 16:21
22/03
Buy 321 616.20p £1,978.00
16:00 - 22/03 16:00
22/03
Sell 2443 618.00p £15,097.74
16:00 - 22/03 16:00
22/03
Sell 1000 618.00p £6,180.00

Trades priced above mid-price at the time a trade is placed are assumed buys, those priced below are assumed sells. Trades priced close to mid-price or declared late are shown N/A. This is not a recommendation. More information.

More trades
×

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.

Security Weight
Celgene Corp 5.88%
Sv Fund Vi Investment 5.04%
Shire PLC ADR 4.74%
Array BioPharma Inc 4.45%
Neurocrine Biosciences Inc 4.09%
Biogen Inc 4.00%
Regeneron Pharmaceuticals Inc 3.98%
Genmab A/S DKK1 3.86%
Sage Therapeutics Inc 3.64%
Vertex Pharmaceuticals Inc 3.56%
Sector Weight
Healthcare 90.58%
Country Weight
United States 81.24%
Denmark 3.86%
Germany 2.65%
France 1.07%
Canada 0.46%
Netherlands 0.45%
Belgium 0.40%
United Kingdom 0.35%
Israel 0.10%

Key Dates

Launch date: 31 March 1994
Financial year end: August
Next AGM: December 2019
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.